Cargando…
Tackling Resistance to Cancer Immunotherapy: What Do We Know?
Cancer treatment has evolved tremendously in the last few decades. Immunotherapy has been considered to be the forth pillar in cancer treatment in addition to conventional surgery, radiotherapy, and chemotherapy. Though immunotherapy has resulted in impressive response, it is generally limited to a...
Autores principales: | Gondhowiardjo, Soehartati A., Handoko, Jayalie, Vito Filbert, Apriantoni, Riyan, Barata, Andreas Ronald, Senoaji, Fajar, Utami, IGAA Jayanthi Wulan, Maubere, Ferdinand, Nuryadi, Endang, Giselvania, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570938/ https://www.ncbi.nlm.nih.gov/pubmed/32911646 http://dx.doi.org/10.3390/molecules25184096 |
Ejemplares similares
-
Relationship of Adherence to Cervical Cancer Treatment Guideline Towards Patients’ Five-year Survival: Systematic Review of Follow-up Trials
por: Putri, Novianti Qurnia, et al.
Publicado: (2020) -
Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses
por: Anton, Jellyca, et al.
Publicado: (2021) -
Deciphering Driver of Nasopharyngeal Cancer Development
por: Handoko,, et al.
Publicado: (2022) -
Patterns of Care and Outcome Analysis of Nasopharyngeal Carcinoma: An Indonesian Single Institution Study
por: Faisal, Hamida Hayati, et al.
Publicado: (2020) -
Ensuring safety and sustainability of radiotherapy services during the COVID-19 pandemic in resources constrain country: An Indonesian experience
por: Handoko, et al.
Publicado: (2020)